|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Restricted cash | ||||||||||||
| Accounts receivable, net of allowance for doubtful accounts | ||||||||||||
| Deferred contract acquisition costs, current | ||||||||||||
| Prepaid expenses and other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Right-of-use assets, net | ||||||||||||
| Deferred contract acquisition costs, non-current | ||||||||||||
| Restricted cash, non-current | ||||||||||||
| Prepaid marketing expense | ||||||||||||
| Other non-current assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | ||||||||||||
| Accrued expenses | ||||||||||||
| Lease liabilities, current | ||||||||||||
| Deferred revenue | ||||||||||||
| Total current liabilities | ||||||||||||
| Lease liabilities, non-current | ||||||||||||
| Other non-current liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| Redeemable common stock, $0.001 par value, 0 and 64,046,223 shares issued and outstanding at December 31, 2023 and 2022, respectively. | ||||||||||||
| Redeemable Common Stock | ||||||||||||
| Total redeemable common stock, $0.001 par value, 0 and 64,046,223 shares issued and outstanding at December 31, 2023 and 2022, respectively. | ||||||||||||
| Stockholders’ Equity | ||||||||||||
| Preferred stock: $0.001 par value; 100,000,000 shares authorized; 0 and 0 shares issued and outstanding at June 30, 2026, and December 31, 2025, respectively. | ||||||||||||
| Common stock | ||||||||||||
| Series A Common Stock | ||||||||||||
| Series B Common Stock | ||||||||||||
| Treasury stock: $0.001 par value; 20,479,864 and 0 shares held at June 30, 2026 and December 31, 2025, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders’ equity | ||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||
| Redeemable common stock, shares outstanding (in shares) | ||||||||||||
| Redeemable Common Stock | ||||||||||||
| Total redeemable common stock, shares outstanding (in shares) | ||||||||||||
| Preferred stock, shares outstanding (in shares) | ||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||
| Series A Common Stock | ||||||||||||
| Series B Common Stock | ||||||||||||
| Common stock, outstanding (in shares) | ||||||||||||
| Series A Common Stock | ||||||||||||
| Series B Common Stock |
Loading...